Ameritas Investment Partners’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-11,893
| Closed | -$72K | – | 3066 |
|
|
2019
Q4 | $72K | Buy |
11,893
+1,775
| +18% | +$10.3K | ﹤0.01% | 1705 |
|
|
2019
Q3 | $36K | Hold |
10,118
| – | – | ﹤0.01% | 2078 |
|
|
2019
Q2 | $27K | Hold |
10,118
| – | – | ﹤0.01% | 2281 |
|
|
2019
Q1 | $30K | Hold |
10,118
| – | – | ﹤0.01% | 2168 |
|
|
2018
Q4 | $16K | Hold |
10,118
| – | – | ﹤0.01% | 2478 |
|
|
2018
Q3 | $37K | Hold |
10,118
| – | – | ﹤0.01% | 2167 |
|
|
2018
Q2 | $29K | Hold |
10,118
| – | – | ﹤0.01% | 2304 |
|
|
2018
Q1 | $38K | Hold |
10,118
| – | – | ﹤0.01% | 2075 |
|
|
2017
Q4 | $29K | Hold |
10,118
| – | – | ﹤0.01% | 2252 |
|
|
2017
Q3 | $51K | Hold |
10,118
| – | – | ﹤0.01% | 1886 |
|
|
2017
Q2 | $46K | Hold |
10,118
| – | – | ﹤0.01% | 1963 |
|
|
2017
Q1 | $43K | Hold |
10,118
| – | – | ﹤0.01% | 1959 |
|
|
2016
Q4 | $42K | Hold |
10,118
| – | – | ﹤0.01% | 1129 |
|
|
2016
Q3 | $82K | Buy |
+10,118
| New | +$86K | ﹤0.01% | 1076 |
|
|
2015
Q2 | – | Sell |
-10,054
| Closed | -$99K | – | 1227 |
|
|
2015
Q1 | $99K | Buy |
+10,054
| New | +$126K | 0.01% | 1058 |
|
Ameritas Investment Partners's ACHN Position: Q1 2020 in Review
Ameritas Investment Partners sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 11,893 shares — an estimated $72K sold.
Ameritas Investment Partners first reported a position in ACHN in Q1 2015 and held it in 15 quarters. The position peaked at $99K in Q1 2015. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Ameritas Investment Partners reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Ameritas Investment Partners sold 11,893 Achillion Pharmaceuticals shares in Q1 2020, an estimated $72K.
- Ameritas Investment Partners first reported a position in Achillion Pharmaceuticals in Q1 2015 and held it in 15 quarters.
- Ameritas Investment Partners's Achillion Pharmaceuticals position peaked at $99K in Q1 2015.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Ameritas Investment Partners's 13F filing for Q1 2020, filed 13 May 2020.